Mackenzie Financial’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.42M Buy
60,217
+36,446
+153% +$4.41M 0.01% 771
2026
Q1
$3.89M Buy
23,771
+2,151
+10% +$331K ﹤0.01% 750
2025
Q4
$3.76M Buy
21,620
+4,801
+29% +$876K ﹤0.01% 703
2025
Q3
$2.42M Buy
16,819
+3,238
+24% +$397K ﹤0.01% 786
2025
Q2
$1.37M Buy
13,581
+478
+4% +$36.5K ﹤0.01% 933
2025
Q1
$1,000K Buy
13,103
+2,220
+20% +$170K ﹤0.01% 983
2024
Q4
$751K Buy
10,883
+1,213
+13% +$87.4K ﹤0.01% 1019
2024
Q3
$706K Buy
9,670
+1,137
+13% +$83.9K ﹤0.01% 942
2024
Q2
$572K Hold
8,533
﹤0.01% 988
2024
Q1
$232K Hold
8,533
﹤0.01% 1284
2023
Q4
$264K Hold
8,533
﹤0.01% 1210
2023
Q3
$208K Buy
+8,533
New +$195K ﹤0.01% 1262

Other funds holding INSM

Mackenzie Financial's INSM Position: Q2 2026 in Review

Mackenzie Financial increased its Insmed (INSM) stake by 153% in Q2 2026, buying an estimated $4.41M and bringing the position to 60,217 shares worth $6.42M. The position accounts for 0.01% of the portfolio, ranked #771.

Mackenzie Financial first reported a position in INSM in Q3 2023 and has held it in 12 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Mackenzie Financial held 60,217 shares of Insmed worth $6.42M as of Q2 2026.
  • Mackenzie Financial bought 36,446 Insmed shares in Q2 2026, an estimated $4.41M.
  • Insmed made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #771 holding.
  • Mackenzie Financial first reported a position in Insmed in Q3 2023 and has held it in 12 quarters since.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.